These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 19150337

  • 21. Flow cytometric analysis of agonist-induced annexin V, factor Va and factor Xa binding to human platelets.
    Dörmann D, Kardoeus J, Zimmermann RE, Kehrel B.
    Platelets; 1998; 9(3-4):171-7. PubMed ID: 16793697
    [Abstract] [Full Text] [Related]

  • 22. Identification of distinct sequences in human blood coagulation factor Xa and prothrombin essential for substrate and cofactor recognition in the prothrombinase complex.
    Yegneswaran S, Mesters RM, Griffin JH.
    J Biol Chem; 2003 Aug 29; 278(35):33312-8. PubMed ID: 12805370
    [Abstract] [Full Text] [Related]

  • 23. Assembly and regulation of prothrombinase complex on B16F10 melanoma cells.
    Kirszberg C, Rumjanek VM, Monteiro RQ.
    Thromb Res; 2005 Aug 29; 115(1-2):123-9. PubMed ID: 15567463
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Exosite occupation by heparin enhances the reactivity of blood coagulation factor IXa.
    Neuenschwander PF.
    Biochemistry; 2004 Mar 16; 43(10):2978-86. PubMed ID: 15005634
    [Abstract] [Full Text] [Related]

  • 26. Phosphatidylserine-induced factor Xa dimerization and binding to factor Va are competing processes in solution.
    Majumder R, Koklic T, Rezaie AR, Lentz BR.
    Biochemistry; 2013 Jan 08; 52(1):143-51. PubMed ID: 23214401
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Determination of antithrombin-dependent factor Xa inhibitors by prothrombin-induced clotting time.
    Harenberg J, Giese C, Hagedorn A, Traeger I, Fenyvesi T.
    Semin Thromb Hemost; 2007 Jul 08; 33(5):503-7. PubMed ID: 17629847
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Approaches to selective peptidic inhibitors of factor Xa.
    Bromfield KM, Quinsey NS, Duggan PJ, Pike RN.
    Chem Biol Drug Des; 2006 Jul 08; 68(1):11-9. PubMed ID: 16923021
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. A non-immunological phospholipid-dependent coagulation inhibitor associated with IgGlambda-type multiple myeloma.
    Takamiya O, Machida S, Okuda M, Nojima J, Koreeda C, Kubara K.
    Am J Hematol; 2004 Jan 08; 75(1):34-9. PubMed ID: 14695630
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.